GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hadasit Bio Holdings Ltd (XTAE:HDST-M) » Definitions » EV-to-Revenue

Hadasit Bio Holdings (XTAE:HDST-M) EV-to-Revenue : 71.56 (As of Dec. 14, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Hadasit Bio Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hadasit Bio Holdings's enterprise value is ₪1.93 Mil. Hadasit Bio Holdings's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was ₪0.03 Mil. Therefore, Hadasit Bio Holdings's EV-to-Revenue for today is 71.56.

The historical rank and industry rank for Hadasit Bio Holdings's EV-to-Revenue or its related term are showing as below:

XTAE:HDST-M' s EV-to-Revenue Range Over the Past 10 Years
Min: -14.75   Med: 480.71   Max: 4550.14
Current: 71.55

During the past 13 years, the highest EV-to-Revenue of Hadasit Bio Holdings was 4550.14. The lowest was -14.75. And the median was 480.71.

XTAE:HDST-M's EV-to-Revenue is ranked worse than
81.57% of 1042 companies
in the Biotechnology industry
Industry Median: 7.65 vs XTAE:HDST-M: 71.55

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-14), Hadasit Bio Holdings's stock price is ₪0.515. Hadasit Bio Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ₪0.00. Therefore, Hadasit Bio Holdings's PS Ratio for today is 171.67.


Hadasit Bio Holdings EV-to-Revenue Historical Data

The historical data trend for Hadasit Bio Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hadasit Bio Holdings EV-to-Revenue Chart

Hadasit Bio Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,647.48 - - - -

Hadasit Bio Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hadasit Bio Holdings's EV-to-Revenue

For the Biotechnology subindustry, Hadasit Bio Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hadasit Bio Holdings's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hadasit Bio Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hadasit Bio Holdings's EV-to-Revenue falls into.



Hadasit Bio Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hadasit Bio Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1.932/0.027
=71.56

Hadasit Bio Holdings's current Enterprise Value is ₪1.93 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hadasit Bio Holdings's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was ₪0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hadasit Bio Holdings  (XTAE:HDST-M) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hadasit Bio Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.515/0.003
=171.67

Hadasit Bio Holdings's share price for today is ₪0.515.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was ₪0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hadasit Bio Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hadasit Bio Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hadasit Bio Holdings Business Description

Traded in Other Exchanges
Address
5th Floor, Jerusaelm Bio-Park, Hadassah Ein-Kerem Campus, Jerusalem, ISR, 91120
Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.

Hadasit Bio Holdings Headlines

No Headlines